Bai Ji

891 total citations
36 papers, 618 citations indexed

About

Bai Ji is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Bai Ji has authored 36 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Bai Ji's work include Pancreatic and Hepatic Oncology Research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Bai Ji is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Bai Ji collaborates with scholars based in China, United States and Canada. Bai Ji's co-authors include Hongqiao Cai, Fei Yan, Yahui Liu, Meiyu Song, Kai Liu, Jianhua Liu, Lingyu Meng, Yang Yang, Songyang Liu and Yahui Liu and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Journal of Controlled Release.

In The Last Decade

Bai Ji

33 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bai Ji China 12 273 215 160 154 111 36 618
Dennis Doleschel Germany 11 148 0.5× 257 1.2× 169 1.1× 62 0.4× 49 0.4× 17 678
Lan Sun China 15 227 0.8× 131 0.6× 180 1.1× 106 0.7× 88 0.8× 32 611
Man Shu China 11 101 0.4× 121 0.6× 145 0.9× 99 0.6× 86 0.8× 25 418
Fuli Xin China 10 103 0.4× 268 1.2× 116 0.7× 61 0.4× 123 1.1× 23 548
Yahui Liu China 10 141 0.5× 223 1.0× 67 0.4× 125 0.8× 32 0.3× 29 435
Chun-Ying Qu China 14 271 1.0× 83 0.4× 104 0.7× 45 0.3× 152 1.4× 25 563
Nancy Paz United States 9 201 0.7× 149 0.7× 226 1.4× 93 0.6× 67 0.6× 21 539
Donghai Jiang China 13 407 1.5× 84 0.4× 144 0.9× 109 0.7× 260 2.3× 24 658
Tianzhu Yu China 12 287 1.1× 98 0.5× 100 0.6× 61 0.4× 106 1.0× 24 571

Countries citing papers authored by Bai Ji

Since Specialization
Citations

This map shows the geographic impact of Bai Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bai Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bai Ji more than expected).

Fields of papers citing papers by Bai Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bai Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bai Ji. The network helps show where Bai Ji may publish in the future.

Co-authorship network of co-authors of Bai Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Bai Ji. A scholar is included among the top collaborators of Bai Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bai Ji. Bai Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Bai, Xiaoyan Li, Huijun Chen, et al.. (2025). Efficacy and safety of a novel treatment scheme of RC48-ADC plus PD-1 inhibitors in metastatic urothelial carcinoma: a multicenter real-world study. Therapeutic Advances in Medical Oncology. 17. 22840664–22840664.
3.
Ji, Bai, et al.. (2025). Efficacy and safety of treatments for notalgia paresthetica: A systematic review. Journal of the European Academy of Dermatology and Venereology.
4.
Cai, Hongqiao, Yahui Liu, Jianji Ke, et al.. (2024). Decitabine-based nanoparticles for enhanced immunotherapy of hepatocellular carcinoma via DNA hypermethylation reversal. Chemical Engineering Journal. 492. 152175–152175. 6 indexed citations
5.
Ke, Jianji, et al.. (2024). Application of the superior mesenteric artery-first approach in laparoscopic pancreatoduodenectomy: A literature review. Heliyon. 10(6). e27500–e27500. 2 indexed citations
6.
Li, Xiaocheng, Jianji Ke, Liang Guo, et al.. (2024). Development of a nomogram for predicting the high-risk groups of solid-pseudopapillary neoplasms of the pancreas. Frontiers in Oncology. 13. 1297497–1297497. 5 indexed citations
7.
Li, Ang, Bai Ji, Yongsheng Yang, et al.. (2023). Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma. Frontiers in Immunology. 14. 1164448–1164448. 11 indexed citations
8.
Cai, Hongqiao, Bai Ji, Songyang Liu, et al.. (2022). Outcomes of laparoscopic pancreaticoduodenectomy using a modified technique:346 cases from a single center. Asian Journal of Surgery. 46(1). 306–313. 1 indexed citations
9.
Li, Zhijun, et al.. (2021). Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis.. Videosurgery and Other Miniinvasive Techniques. 16(3). 455–471. 8 indexed citations
10.
11.
12.
Cai, Hongqiao, Lingxiao Zhang, Kunxia Cao, et al.. (2021). Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma. Acta Biomaterialia. 127. 276–286. 55 indexed citations
13.
Ke, Jianji, Yahui Liu, Feiqi Liu, & Bai Ji. (2020). Application of Laparoscopic Pancreatoduodenectomy in Elderly Patients. Journal of Laparoendoscopic & Advanced Surgical Techniques. 30(7). 797–802. 8 indexed citations
14.
Ji, Bai, Hongqiao Cai, Yang Yang, et al.. (2020). Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma. Acta Biomaterialia. 111. 363–372. 95 indexed citations
15.
Cai, Hongqiao, et al.. (2019). Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells. International Journal of Medical Sciences. 16(12). 1541–1548. 35 indexed citations
16.
Liu, Jianhua, et al.. (2017). Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma. Oncology Reports. 38(2). 899–907. 78 indexed citations
17.
Jia, Baoxing, Bai Ji, Zhe Jin, et al.. (2014). Acute severe cholecystitis treated by percutaneous transhepatic gallbladder drainage combined with laparoscopic cholecystectomy. Zhonghua gan-dan waike zazhi. 20(11). 802–804. 1 indexed citations
18.
Liu, Songyang, Wei Zhang, Kai Liu, Bai Ji, & Guangyi Wang. (2014). Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells. Molecular Medicine Reports. 11(1). 597–602. 26 indexed citations
19.
Zhang, Wei, Songyang Liu, Kai Liu, et al.. (2014). Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo. Oncology Reports. 32(5). 1913–1922. 17 indexed citations
20.
Ji, Bai. (2013). Clinical Characteristics of Clostridium Difficile-associated Diarrhea and Prevention Strategy. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026